Maduck Sean's most recent trade in Corcept Therapeutics Inc was a trade of 4,315 Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on July 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 17 Jul 2025 | 4,315 | 22,020 (0%) | 0% | 5.1 | 21,791 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 4,315 | 57,466 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.48 per share. | 17 Jul 2025 | 4,315 | 17,705 (0%) | 0% | 73.5 | 317,054 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 473 | 56,993 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.44 per share. | 17 Jul 2025 | 473 | 17,705 (0%) | 0% | 73.4 | 34,737 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 17 Jul 2025 | 473 | 18,178 (0%) | 0% | 5.1 | 2,389 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 Jul 2025 | 205 | 17,910 (0%) | 0% | 5.0 | 1,035 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 205 | 61,781 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 73.45 per share. | 01 Jul 2025 | 205 | 17,705 (0%) | 0% | 73.5 | 15,058 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jun 2025 | 40,000 | 59,717 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Other type of transaction at price $ 0.00 per share. | 12 Jun 2025 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 12 Jun 2025 | 35,007 | 42,688 (0%) | 0% | 5.0 | 176,785 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 35,007 | 21,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 67.53 per share. | 12 Jun 2025 | 27,865 | 14,823 (0%) | 0% | 67.5 | 1,881,818 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jun 2025 | 10,024 | 7,681 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Other type of transaction at price $ 0.00 per share. | 12 Jun 2025 | 10,024 | 99,717 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 68.52 per share. | 12 Jun 2025 | 5,428 | 9,395 (0%) | 0% | 68.5 | 371,952 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 69.70 per share. | 12 Jun 2025 | 1,714 | 7,681 (0%) | 0% | 69.7 | 119,467 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 5.05 per share. | 02 Jun 2025 | 20,000 | 37,705 (0%) | 0% | 5.1 | 101,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 20,000 | 61,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 79.89 per share. | 02 Jun 2025 | 6,246 | 19,516 (0%) | 0% | 79.9 | 498,967 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 78.87 per share. | 02 Jun 2025 | 6,191 | 25,762 (0%) | 0% | 78.9 | 488,311 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 77.91 per share. | 02 Jun 2025 | 5,752 | 31,953 (0%) | 0% | 77.9 | 448,139 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 80.77 per share. | 02 Jun 2025 | 1,811 | 17,705 (0%) | 0% | 80.8 | 146,269 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 888 | 17,705 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 71.68 per share. | 02 Jun 2025 | 888 | 16,817 (0%) | 0% | 71.7 | 63,652 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 May 2025 | 26,554 | 112,176 (0%) | 0% | 5.1 | 134,098 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 26,554 | 81,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 72.21 per share. | 01 May 2025 | 25,847 | 86,329 (0%) | 0% | 72.2 | 1,866,355 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 71.94 per share. | 01 May 2025 | 12,856 | 85,622 (0%) | 0% | 71.9 | 924,818 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 01 May 2025 | 12,856 | 98,478 (0%) | 0% | 5.1 | 64,923 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 12,856 | 108,540 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 72.98 per share. | 01 May 2025 | 707 | 85,622 (0%) | 0% | 73.0 | 51,596 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.27 per share. | 31 Mar 2025 | 100,000 | 185,622 (0%) | 0% | 8.3 | 827,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 100,000 | 300,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 100.26 per share. | 31 Mar 2025 | 79,277 | 106,345 (0%) | 0% | 100.3 | 7,947,995 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 101.43 per share. | 31 Mar 2025 | 15,133 | 91,212 (0%) | 0% | 101.4 | 1,534,937 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 102.16 per share. | 31 Mar 2025 | 5,590 | 85,622 (0%) | 0% | 102.2 | 571,078 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 590 | 121,396 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 114.55 per share. | 31 Mar 2025 | 590 | 85,622 (0%) | 0% | 114.5 | 67,584 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 31 Mar 2025 | 590 | 86,212 (0%) | 0% | 5.1 | 2,980 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 24 Mar 2025 | 1,697 | 87,319 (0%) | 0% | 5.1 | 8,570 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 60.58 per share. | 24 Mar 2025 | 1,697 | 85,622 (0%) | 0% | 60.6 | 102,804 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 1,697 | 121,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 60.69 per share. | 28 Feb 2025 | 18,303 | 85,622 (0%) | 0% | 60.7 | 1,110,818 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 18,303 | 123,683 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 28 Feb 2025 | 18,303 | 103,925 (0%) | 0% | 5.0 | 92,430 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 59.07 per share. | 28 Feb 2025 | 266 | 85,356 (0%) | 0% | 59.1 | 15,713 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 266 | 85,622 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.58 per share. | 28 Feb 2025 | 228 | 85,090 (0%) | 0% | 60.6 | 13,812 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 66.92 per share. | 03 Feb 2025 | 20,000 | 85,318 (0%) | 0% | 66.9 | 1,338,400 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 11,986 | 10,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 03 Feb 2025 | 11,986 | 97,304 (0%) | 0% | 3.9 | 46,506 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 03 Feb 2025 | 8,014 | 105,318 (0%) | 0% | 5.1 | 40,471 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 8,014 | 141,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 20,000 | 21,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 02 Jan 2025 | 20,000 | 105,318 (0%) | 0% | 3.9 | 77,600 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 50.39 per share. | 02 Jan 2025 | 20,000 | 85,318 (0%) | 0% | 50.4 | 1,007,800 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.68 per share. | 02 Dec 2024 | 295 | 84,788 (0%) | 0% | 57.7 | 17,016 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 265 | 85,318 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 59.21 per share. | 02 Dec 2024 | 265 | 85,053 (0%) | 0% | 59.2 | 15,691 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 458 | 85,083 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 34.26 per share. | 03 Sep 2024 | 458 | 84,625 (0%) | 0% | 34.3 | 15,691 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.30 per share. | 03 Sep 2024 | 232 | 84,167 (0%) | 0% | 35.3 | 8,190 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.17 per share. | 03 Jun 2024 | 823 | 84,399 (0%) | 0% | 30.2 | 24,830 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2024 | 50,000 | 41,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 13 May 2024 | 50,000 | 135,222 (0%) | 0% | 3.9 | 194,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 13 May 2024 | 50,000 | 85,222 (0%) | 0% | 28 | 1,400,000 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 25.01 per share. | 27 Mar 2024 | 25,953 | 85,222 (0%) | 0% | 25.0 | 649,025 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 25,953 | 91,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 27 Mar 2024 | 25,953 | 111,175 (0%) | 0% | 3.9 | 100,698 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 18 Mar 2024 | 17,219 | 75,222 (0%) | 0% | 25 | 430,475 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 18 Mar 2024 | 17,219 | 92,441 (0%) | 0% | 3.9 | 66,810 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 17,219 | 117,939 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 10,000 | 0 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.61 per share. | 18 Mar 2024 | 10,000 | 85,222 (0%) | 0% | 2.6 | 26,100 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 636 | 75,222 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 24.06 per share. | 01 Mar 2024 | 636 | 74,586 (0%) | 0% | 24.1 | 15,302 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 01 Mar 2024 | 505 | 73,950 (0%) | 0% | 24.1 | 12,150 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Sale of securities on an exchange or to another person at price $ 25.97 per share. | 15 Feb 2024 | 27,068 | 74,455 (0%) | 0% | 26.0 | 702,905 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 14,842 | 135,158 | - | - | Stock Option (right to buy) | |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 15 Feb 2024 | 14,842 | 101,523 (0%) | 0% | 3.9 | 57,587 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 12,226 | 0 | - | - | Stock Option (right to buy) | |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 15 Feb 2024 | 12,226 | 86,681 (0%) | 0% | 3.3 | 40,224 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 15 Feb 2024 | 4,760 | 79,215 (0%) | 0% | 3.3 | 15,660 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 15 Feb 2024 | 4,760 | 74,455 (0%) | 0% | 25 | 119,000 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,760 | 12,226 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Sale of securities on an exchange or to another person at price $ 25.56 per share. | 01 Dec 2023 | 25,000 | 73,291 (0%) | 0% | 25.6 | 639,048 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 01 Dec 2023 | 14,991 | 98,291 (0%) | 0% | 3.3 | 49,320 | Common Stock |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 14,991 | 16,986 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 10,009 | 10,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.61 per share. | 01 Dec 2023 | 10,009 | 83,300 (0%) | 0% | 2.6 | 26,123 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 582 | 74,455 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Grant, award, or other acquisition of securities at price $ 25.97 per share. | 01 Dec 2023 | 582 | 73,873 (0%) | 0% | 26.0 | 15,115 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 10,000 | 0 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.92 per share. | 17 Jul 2023 | 10,000 | 72,698 (0%) | 0% | 1.9 | 19,200 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 1,658 | 62,698 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 22.97 per share. | 01 Jun 2023 | 1,658 | 61,040 (0%) | 0% | 23.0 | 38,084 | Common Stock |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 19.86 per share. | 01 Mar 2023 | 1,460 | 57,922 (0%) | 0% | 19.9 | 28,996 | Common Stock |